Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Alnylam Pharmaceuticals Inc ALNY

Sector: Healthcare | Sub-Sector: Biotechnology

Alnylam Pharmaceuticals Inc is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi.
Price: $119.01 Volume: 322,919
Change: +$0.29 % Change: +0.24%
Day High/Low: 120.28/116.81 52 Week High/Low: 132.99/47.03
Last Traded: April 24, 2015 12:00 Transaction Volume: 7600
Open: 118.04 Previous Close: 118.72
Bid: Ask:
Bid Size: 0 Ask Size: 0
Market Cap: 10b Shares Out: 84.0m
PE Ratio: N/A Dividend Yield: N/A

Latest Bullboard Posts

  • Stepping up today

    0 stars

    I am getting my feet wet in this as I believe it is on the threshold of some exciting developments with respect to 'RNA Interference...

    2 stars


  • ALNY Short Squeeze

    0 stars

    With the press release today, there's a squeeze happening with the ALNY short-sellers.  Volume has hit approximately 3.5 million today...

    1.5 stars


  • Bought last week

    0 stars

    Alnylam announced last Tuesday that it has filed to sell 7.5 million shares of common stock at $10.75 a share, with the intent of raising...

    0 stars


  • Not gonna be good ALNY

    0 stars

    TKM gets an injunction from BC coutrs for alleged documents pilfered from TKM computer files. Wil carry substantial wieght IMO in the...

    2.5 stars


  • Tekmira receives milestone payments for ALN-TTR01

    0 stars

    Tekmira receives milestone payments of up to US$16 from Alnylam for TTR01...From Tekmira Website:"Alnylam has broad access to Tekmira’s...

    2.5 stars